Phase Ⅳ Clinical Trial of Recombinant Hepatitis E Vaccine（Hecolin®）

Updated 06/21/2024

Status Completed

Clinical Trial Summary

The purpose of this study is to determine the safety and immunogenicity of the recombinant hepatitis E vaccine in people older than 65 years, and evaluate the efficacy of hepatitis E vaccine in this population.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02189603
Study type	Interventional
Source	Xiamen University
Contact
Status	Completed
Phase	Phase 4
Start date	June 2014
Completion date	December 7, 2015

See also
	Status	Clinical Trial	Phase
	Completed	`NCT03365921` - A Phase Ⅳ Clinical Trial of the Recombinant Hepatitis E Vaccine (Escherichia Coli)(the Lot Consistency Trial)	Phase 4
	Completed	`NCT02584543` - A Phase Ⅳ Clinical Trial of the Recombinant Hepatitis E Vaccine (Escherichia Coli)(Coadministration With Recombinant Hepatitis B Vaccine)	Phase 4
	Not yet recruiting	`NCT03488589` - HEV in Patients With Acute Non-A, Non-B, Non-C Hepatitis in Al-Rajhy University Hospital for Liver
	Completed	`NCT03601221` - Seroprevalence Hepatitis E Infection in Healthy Blood Donors
	Completed	`NCT03168412` - A Study on the Recombinant Hepatitis E Vaccine (Escherichia Coli) (Accelerated Vaccination Schedule)	Phase 4
	Completed	`NCT02847507` - Seroprevalence of Hepatitis E in HIV Positive Patients in Basque Country in 2016 (VIhVhEpb)
	Completed	`NCT02603055` - A Clinical Trial to Evaluate a Recombinant Hepatitis E Vaccine in Healthy Adults	Phase 1
	Completed	`NCT02190253` - Seroprevalence of Hepatitis E in People With an Organ Transplant
	Recruiting	`NCT06457438` - Molecular Characteristics and Prevalence of Viral Hepatitis E in Human Tissue and Cell Donors	N/A
	Completed	`NCT04670419` - Morbidity and Mortality of Hepatitis E Virus Infections in Belgium
	Completed	`NCT03282474` - HepNet Pilot Trial: Multicenter Trial for the Treatment of Chronic Hepatitis E With Sofosbuvir (SofE)	Phase 2
	Terminated	`NCT02558114` - Ribavirin for Severe Acute and Chronic Hepatitis E Virus Infection.	Phase 4
	Recruiting	`NCT06137313` - Exposure to Hepatitis E Virus in Occitania, France
	Completed	`NCT02964910` - A Phase Ⅳ Clinical Trial of the Recombinant Hepatitis E Vaccine (Escherichia Coli)(the Chronic Hepatitis B Patients )	Phase 4
	Completed	`NCT01014845` - Clinical Trial of Recombinant Hepatitis E Vaccine	Phase 3
	Recruiting	`NCT05976594` - Long-term Effectiveness of a Recombinant Hepatitis E Vaccine
	Completed	`NCT02417597` - A Phase Ⅳ Clinical Trial of the Recombinant Hepatitis E Vaccine (Escherichia Coli)	Phase 4
	Completed	`NCT03827395` - Safety Study of Hepatitis E Vaccine (HEV239)	Phase 1